SBIO
Fund Stats as of 04/25/2018
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $33.96
Last Trade Price $33.95
NAV $33.93
NAV Change $-0.03
Total Net Assets $171,331,378
Total Market Value $171,331,858
Premium/Discount(%) 0.09%
Difference ($) $0.03
Volume 23,586
Shares Outstanding 5,050,000
Expenses as of 03/31/2018
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Statutory Prospectus 
Resource Library  

Daily Fund Holdings 96 total, as of 04/25/2018, subject to change

SecuritySymbolWeight
BeiGene Ltd.BGNE5.29%
Sarepta Therapeutics Inc.SRPT3.86%
Agios Pharmaceuticals Inc.AGIO3.61%
Galapagos NVGLPG3.58%
Taro Pharmaceutical Industries Ltd.TARO3.12%
Loxo Oncology Inc.LOXO3.04%
FibroGen Inc.FGEN2.94%
GW Pharmaceuticals PLCGWPH2.69%
Ligand Pharmaceuticals Inc.LGND2.51%
Array BioPharma Inc.ARRY2.20%
TESARO Inc.TSRO2.16%
Spark Therapeutics Inc.ONCE2.10%
Immunomedics Inc.IMMU2.06%
Halozyme Therapeutics Inc.HALO2.05%
Emergent BioSolutions Inc.EBS1.98%
Supernus Pharmaceuticals Inc.SUPN1.87%
Ascendis Pharma ASASND1.79%
Ironwood Pharmaceuticals Inc.IRWD1.76%
Horizon Pharma PLCHZNP1.72%
Clovis Oncology Inc.CLVS1.70%
Portola Pharmaceuticals Inc.PTLA1.68%
Global Blood Therapeutics Inc.GBT1.58%
Aerie Pharmaceuticals Inc.AERI1.57%
AnaptysBio Inc.ANAB1.54%
Heron Therapeutics Inc.HRTX1.51%
Insmed Inc.INSM1.48%
MyoKardia Inc.MYOK1.37%
Aimmune Therapeutics Inc.AIMT1.34%
Atara Biotherapeutics Inc.ATRA1.31%
Akorn Inc.AKRX1.30%
Enanta Pharmaceuticals Inc.ENTA1.29%
Acceleron Pharma Inc.XLRN1.23%
Arena Pharmaceuticals Inc.ARNA1.22%
Madrigal Pharmaceuticals Inc.MDGL1.17%
Radius Health Inc.RDUS1.10%
Impax Laboratories Inc.IPXL1.09%
Pacira Pharmaceuticals Inc.PCRX1.07%
ImmunoGen Inc.IMGN1.05%
Endo International PLCENDP0.97%
Theravance Biopharma Inc.TBPH0.97%
Adaptimmune Therapeutics PLCADAP0.90%
PTC Therapeutics Inc.PTCT0.88%
Dynavax Technologies Corp.DVAX0.87%
G1 Therapeutics Inc.GTHX0.86%
DBV Technologies SADBVT0.85%
Acorda Therapeutics Inc.ACOR0.83%
Revance Therapeutics Inc.RVNC0.78%
Athenex Inc.ATNX0.76%
Flexion Therapeutics Inc.FLXN0.73%
Epizyme Inc.EPZM0.72%
UroGen Pharma Ltd.URGN0.67%
Amarin Corp. PLCAMRN0.60%
NuCana PLCNCNA0.58%
Adamas Pharmaceuticals Inc.ADMS0.57%
AMAG Pharmaceuticals Inc.AMAG0.52%
Jounce Therapeutics Inc.JNCE0.48%
Rhythm Pharmaceuticals Inc.RYTM0.47%
Lannett Co. Inc.LCI0.46%
Arrowhead Pharmaceuticals Inc.ARWR0.44%
Five Prime Therapeutics Inc.FPRX0.44%
GlycoMimetics Inc.GLYC0.44%
Aclaris Therapeutics Inc.ACRS0.42%
Clementia Pharmaceuticals Inc.CMTA0.40%
Reata Pharmaceuticals Inc.RETA0.39%
Aduro Biotech Inc.ADRO0.39%
Achillion Pharmaceuticals Inc.ACHN0.39%
Progenics Pharmaceuticals Inc.PGNX0.38%
BioCryst Pharmaceuticals Inc.BCRX0.37%
MediciNova Inc.MNOV0.35%
Kura Oncology Inc.KURA0.34%
Akebia Therapeutics Inc.AKBA0.34%
PDL BioPharma Inc.PDLI0.34%
Depomed Inc.DEPO0.32%
Concert Pharmaceuticals Inc.CNCE0.32%
Paratek Pharmaceuticals Inc.PRTK0.26%
NantKwest Inc.NK0.24%
Aquinox Pharmaceuticals Inc.AQXP0.23%
Seres Therapeutics Inc.MCRB0.23%
Avadel Pharmaceuticals PLCAVDL0.22%
Catalyst Pharmaceuticals Inc.CPRX0.21%
Minerva Neurosciences Inc.NERV0.20%
Savara Inc.SVRA0.20%
Selecta Biosciences Inc.SELB0.20%
Syndax Pharmaceuticals Inc.SNDX0.19%
Chimerix Inc.CMRX0.18%
Molecular Templates Inc.MTEM0.17%
Calithera Biosciences Inc.CALA0.16%
Tocagen Inc.TOCA0.15%
XOMA Corp.XOMA0.15%
Ra Pharmaceuticals Inc.RARX0.14%
Protagonist Therapeutics Inc.PTGX0.14%
Zynerba Pharmaceuticals Inc.ZYNE0.11%
Vascular Biogenics Ltd.VBLT0.05%
Dyax Corp. - CVRDYAX-CVR0.00%
State Street Institutional Treasury Plus Money Market FundTPIXX0.10%
Cash and Equivalents0.00%
Total Net Assets 100.00%
Security
BeiGene Ltd.
Sarepta Therapeutics Inc.
Agios Pharmaceuticals Inc.
Galapagos NV
Taro Pharmaceutical Industries Ltd.
Loxo Oncology Inc.
FibroGen Inc.
GW Pharmaceuticals PLC
Ligand Pharmaceuticals Inc.
Array BioPharma Inc.
TESARO Inc.
Spark Therapeutics Inc.
Immunomedics Inc.
Halozyme Therapeutics Inc.
Emergent BioSolutions Inc.
Supernus Pharmaceuticals Inc.
Ascendis Pharma AS
Ironwood Pharmaceuticals Inc.
Horizon Pharma PLC
Clovis Oncology Inc.
Portola Pharmaceuticals Inc.
Global Blood Therapeutics Inc.
Aerie Pharmaceuticals Inc.
AnaptysBio Inc.
Heron Therapeutics Inc.
Insmed Inc.
MyoKardia Inc.
Aimmune Therapeutics Inc.
Atara Biotherapeutics Inc.
Akorn Inc.
Enanta Pharmaceuticals Inc.
Acceleron Pharma Inc.
Arena Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc.
Radius Health Inc.
Impax Laboratories Inc.
Pacira Pharmaceuticals Inc.
ImmunoGen Inc.
Endo International PLC
Theravance Biopharma Inc.
Adaptimmune Therapeutics PLC
PTC Therapeutics Inc.
Dynavax Technologies Corp.
G1 Therapeutics Inc.
DBV Technologies SA
Acorda Therapeutics Inc.
Revance Therapeutics Inc.
Athenex Inc.
Flexion Therapeutics Inc.
Epizyme Inc.
UroGen Pharma Ltd.
Amarin Corp. PLC
NuCana PLC
Adamas Pharmaceuticals Inc.
AMAG Pharmaceuticals Inc.
Jounce Therapeutics Inc.
Rhythm Pharmaceuticals Inc.
Lannett Co. Inc.
Arrowhead Pharmaceuticals Inc.
Five Prime Therapeutics Inc.
GlycoMimetics Inc.
Aclaris Therapeutics Inc.
Clementia Pharmaceuticals Inc.
Reata Pharmaceuticals Inc.
Aduro Biotech Inc.
Achillion Pharmaceuticals Inc.
Progenics Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc.
MediciNova Inc.
Kura Oncology Inc.
Akebia Therapeutics Inc.
PDL BioPharma Inc.
Depomed Inc.
Concert Pharmaceuticals Inc.
Paratek Pharmaceuticals Inc.
NantKwest Inc.
Aquinox Pharmaceuticals Inc.
Seres Therapeutics Inc.
Avadel Pharmaceuticals PLC
Catalyst Pharmaceuticals Inc.
Minerva Neurosciences Inc.
Savara Inc.
Selecta Biosciences Inc.
Syndax Pharmaceuticals Inc.
Chimerix Inc.
Molecular Templates Inc.
Calithera Biosciences Inc.
Tocagen Inc.
XOMA Corp.
Ra Pharmaceuticals Inc.
Protagonist Therapeutics Inc.
Zynerba Pharmaceuticals Inc.
Vascular Biogenics Ltd.
Dyax Corp. - CVR
State Street Institutional Treasury Plus Money Market Fund
Cash and Equivalents
Total Net Assets